Navigation Links
Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date
Date:4/30/2009

CRANBURY, N.J., April 30 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) will announce first quarter 2009 financial results after the regular close of markets on Thursday, May 7, 2009. The results announcement will be followed by a live conference call and webcast that afternoon at 5 p.m. EDT.

Interested participants and investors may access the conference call at 5 p.m. EDT by dialing 877-874-1565 (U.S./Canada) or 719-325-4830 (international). A telephonic replay of the call will be available for seven days beginning at 8 p.m. EDT. Access numbers for this replay are 888-203-1112 (U.S./Canada) and 719-457-0820 (international); participant code 5114983.

An audio webcast can also be accessed via the investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under Investors: Events and Presentations. Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to register, download and install any necessary software. After the live webcast, an audio webcast replay will remain available in the Investors section of the Amicus Therapeutics Web site for 30 days.

Amicus' press releases are available at www.amicustherapeutics.com.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal stora
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
2. Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting
3. Amicus Therapeutics to Present at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
4. Amicus Therapeutics Announces Change to Board of Directors
5. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
6. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
7. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
8. Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference
9. Amicus Therapeutics Announces Third Quarter 2008 Financial Results
10. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
11. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 23, 2014 SoundConnect’s ... designed to introduce cutting edge communication technology, ... partners of platform upgrades. This webinar series ... users in their quest to leverage web ... According to SoundConnect’s Marketing Manager, Seanna Baumgartner, ...
(Date:12/24/2014)... 2014 Nashville Fertility Center announced that ... for the American Society for Reproductive Medicine (ASRM), a ... in reproductive medicine. In his new role as ... executive board and will have a voice in furthering ... actively supported ASRM since 1984 when he joined while ...
(Date:12/24/2014)... Texas , Dec. 23, 2014 ... company focused on gynecologic disease, announced today that ... Schuler , Birchview Fund LLC and several Vermillion ... of unregistered shares of Vermillion,s common stock and ... stock in a private placement.  ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014  NeuroLifeSciences ... of mazindol in children with attention deficit/hyperactivity disorder published ... 2014 . The paper, titled "Pilot ... deficit/hyperactivity disorder" ( Konofal et al, Drug ... 2014 ) shows that mazindol might be an ...
Breaking Biology Technology:SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3
... January 22 Amsterdam Molecular,Therapeutics (Euronext: AMT), a leader ... Dr. Ronald H.W. Lorijn will for personal reasons retire,as ... van,Deventer, AMT,s chief scientific officer and co-founder of the ... basis. , Since Ronald Lorijn ...
... MichBio, the association for,Michigan,s biosciences industry, is ... Michigan Biosciences Directory and Resource Guide, the most,comprehensive ... and,organizations. The directory will be included in the ... spotlighting Michigan,biosciences news and trends. , ...
... NEW ROCHELLE, N.Y., Jan. 22 Biotechnology companies ... microfluidics techniques over the past decade and are ... in three years, reports Genetic Engineering and ... ). The technology offers a number of advantages, ...
Cached Biology Technology:AMT CEO Ronald Lorijn Steps Down 2AMT CEO Ronald Lorijn Steps Down 3MichBio Will Publish 2009 Michigan Biosciences Directory and Resource Guide 2GEN Reports on Growing Reliance on Microfluidics Technology 2
(Date:12/19/2014)... , Dec. 18, 2014  23andMe, Inc., the leading ... study that pinpoints fine-scale differences in genetic ancestry of ... . Since immigrants first arrived more than ... has served as a meeting place for ... history and the ongoing mixing of peoples with African, ...
(Date:12/17/2014)... BELVOIR, Va. , Dec. 15, 2014 /PRNewswire-USNewswire/ ... efforts to make it easier to detect and ... chain. Today the agency started performing ... The capability will validate the authenticity of purchased ... chain. The new quality control measures will be ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and ... the addition of the "Global Chemical Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 ... the increasing demand for medical sensors in biomedical ... data for quick and correct diagnosis during surgical ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... With the increasing popularity of whitening one,s teeth, ... of the University of Rochester Medical Center, set out ... tooth from using whitening products. Eastman Institute,s YanFang ... effects of 6 percent hydrogen peroxide, the common ingredient ...
... cellular backup of our brain. These cells are capable ... into neurons, astrocytes or oligodendrocytes. Astrocytes have supportive functions ... myelin layer around axons in order to accelerate neuronal ... know" which way it is supposed to develop? On ...
... will present societal awards to five distinguished ecologists at ... Albuquerque, New Mexico. More than 3,500 attendees are expected ... Steven Hubbell , Steven Hubbell of the University of ... will receive this year,s Eminent Ecologist Award, given to ...
Cached Biology News:OJ worse for teeth than whitening says Eastman Institute researchers 2Neural stem cell differentiation factor discovered 2Ecological Society of America announces 2009 award recipients 2Ecological Society of America announces 2009 award recipients 3
... for hunting and analyzing the rare ... EST sequencing projects, microarrays, functional screenings ... well suited for the normalization of ... though, is specially developed for normalization ...
... has 20 years of expertise in the ... still offers the most powerful systems on ... to 40 000 in-microplate tests requiring incubation ... of different modules (such as worktable shaker ...
... JMP 6 delivers enhanced statistics and ... and quality improvement managers. As an ... JMP 6 simplifies statistics for novice ... needed by experts. It offers a ...
Glycerol-based mounting medium for immunofluorescence microscopy. Formulated to retard photobleaching of fluorochromes such as fluorescein and rhodamine. Product can also be used as a diluent for fl...
Biology Products: